file:: [lee-man-jong-impact-of-high-flow-nasal-cannula_1681816389746_0.pdf](../assets/lee-man-jong-impact-of-high-flow-nasal-cannula_1681816389746_0.pdf)
file-path:: ../assets/lee-man-jong-impact-of-high-flow-nasal-cannula_1681816389746_0.pdf

- The primary end point of hypoxia events occurred less frequently in the group of receiving HFNC oxygenation than in the group of receiving low-flow nasal cannula oxygenation (4% vs. 13%, p = 0.031)
  ls-type:: annotation
  hl-page:: 5
  hl-color:: yellow
  id:: 643e7bd9-962c-4780-b0b8-374d702bd454
- An initial bolus of propofol (0.5–1 mg/kg) was administered intravenously, followed by a repeated bolus (10–20 mg) according to the patient’s condition, or continuous propofol infusion (2–6 mg/kg/h, with an additional bolus administered as needed).
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 643e7c07-810f-437c-a104-720c2880d285